Onyx Biotec Limited (NSE:ONYX)

Onyx Biotec Statistics

Total Valuation

Onyx Biotec has a market cap or net worth of INR 540.34 million. The enterprise value is 651.68 million.

Market Cap	540.34M
Enterprise Value	651.68M

Important Dates

The last earnings date was Thursday, May 14, 2026.

Earnings Date	May 14, 2026
Ex-Dividend Date	n/a

Share Statistics

Onyx Biotec has 18.13 million shares outstanding. The number of shares has increased by 19.26% in one year.

Current Share Class	18.13M
Shares Outstanding	18.13M
Shares Change (YoY)	+19.26%
Shares Change (QoQ)	+8.27%
Owned by Insiders (%)	65.89%
Owned by Institutions (%)	n/a
Float	5.91M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.77
PB Ratio	0.98
P/TBV Ratio	0.98
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 16.96, with an EV/FCF ratio of -10.06.

EV / Earnings	-303.95
EV / Sales	0.93
EV / EBITDA	16.96
EV / EBIT	82.51
EV / FCF	-10.06

Financial Position

The company has a current ratio of 1.58, with a Debt / Equity ratio of 0.27.

Current Ratio	1.58
Quick Ratio	0.97
Debt / Equity	0.27
Debt / EBITDA	3.95
Debt / FCF	-2.34
Interest Coverage	0.65

Financial Efficiency

Return on equity (ROE) is -0.39% and return on invested capital (ROIC) is 1.19%.

Return on Equity (ROE)	-0.39%
Return on Assets (ROA)	0.53%
Return on Invested Capital (ROIC)	1.19%
Return on Capital Employed (ROCE)	1.26%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	1.96M
Profits Per Employee	-6,006
Employee Count	357
Asset Turnover	0.75
Inventory Turnover	3.43

Taxes

Income Tax	-2.07M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -42.58% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-42.58%
50-Day Moving Average	32.89
200-Day Moving Average	39.89
Relative Strength Index (RSI)	49.91
Average Volume (20 Days)	98,600

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Onyx Biotec had revenue of INR 699.14 million and -2.14 million in losses. Loss per share was -0.12.

Revenue	699.14M
Gross Profit	182.61M
Operating Income	7.90M
Pretax Income	-4.22M
Net Income	-2.14M
EBITDA	38.42M
EBIT	7.90M
Loss Per Share	-0.12

Balance Sheet

The company has 40.37 million in cash and 151.71 million in debt, with a net cash position of -111.34 million or -6.14 per share.

Cash & Cash Equivalents	40.37M
Total Debt	151.71M
Net Cash	-111.34M
Net Cash Per Share	-6.14
Equity (Book Value)	554.08M
Book Value Per Share	31.26
Working Capital	187.51M

Cash Flow

In the last 12 months, operating cash flow was -14.94 million and capital expenditures -49.87 million, giving a free cash flow of -64.81 million.

Operating Cash Flow	-14.94M
Capital Expenditures	-49.87M
Depreciation & Amortization	30.52M
Net Borrowing	27.14M
Free Cash Flow	-64.81M
FCF Per Share	-3.57

Margins

Gross margin is 26.12%, with operating and profit margins of 1.13% and -0.31%.

Gross Margin	26.12%
Operating Margin	1.13%
Pretax Margin	-0.60%
Profit Margin	-0.31%
EBITDA Margin	5.49%
EBIT Margin	1.13%
FCF Margin	n/a

Dividends & Yields

Onyx Biotec does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-19.26%
Shareholder Yield	-19.26%
Earnings Yield	-0.40%
FCF Yield	-11.99%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2